AMACR Monoclonal Antibody(4A12)

This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene.

The AMACR Monoclonal Antibody (4A12) is a highly advanced and meticulously developed product that serves as a valuable tool in various scientific and medical applications. This antibody, derived from a monoclonal source, exhibits exceptional specificity and sensitivity towards alpha-methylacyl-CoA racemase (AMACR), a crucial enzyme involved in fatty acid metabolism.

With its unparalleled precision, the AMACR Monoclonal Antibody (4A12) enables researchers and clinicians to accurately detect and quantify AMACR expression levels in tissue samples. This antibody's exceptional affinity towards AMACR ensures reliable and reproducible results, making it an indispensable asset in cancer research, diagnostic pathology, and drug development.

The AMACR Monoclonal Antibody (4A12) is manufactured using state-of-the-art techniques, ensuring consistent quality and performance. Its exceptional specificity minimizes the risk of cross-reactivity, guaranteeing accurate and reliable outcomes. This antibody's high sensitivity allows for the detection of even low levels of AMACR expression, facilitating precise analysis and interpretation of experimental data.

Furthermore, the AMACR Monoclonal Antibody (4A12) is designed to be compatible with various experimental techniques, including immunohistochemistry, western blotting, and enzyme-linked immunosorbent assay (ELISA). Its versatility allows for seamless integration into existing laboratory protocols, enhancing workflow efficiency and productivity.

In summary, the AMACR Monoclonal Antibody (4A12) is a cutting-edge product that offers unparalleled specificity, sensitivity, and versatility. Its exceptional performance and compatibility with various techniques make it an indispensable tool for researchers and clinicians alike, enabling groundbreaking advancements in the fields of cancer research, diagnostic pathology, and drug development.